Browse Products Alphabetically
< Back
Skinbright Active image
Skinbright Active on sale
WAS:  (EX. VAT) 10 ml £6.47
Price: (inc. VAT) £7.76

NOW: (EX. VAT) 10 ml £5.50
Price: (inc. VAT) £6.60

Skinbright Active

Share This
Share This Page
X

A very good and safe skin brightener/lightener, which is patented and has shown no cytotoxic effects, nor any irritation or sensitisation reaction.

15% off!

Best before date of end of January 2020. If you are viewing this page in our Active Ingredients category and not on our Short Dated Deals page click here to read about why shorter dates don't mean the product isn't as good as new and they can be a great bargain!

 

Skinbright Active is a mix that we’ve blended at Aromantic with Organic Cold Pressed Sunflower Oil, which helps to give it an extra natural silicon feeling.
 

Inci:

Helianthus Annus Seed Oil, Dimethylmethoxy Chromanyl Palmitate
  • Induces a significant lightening effect on the skin, at the same time that fights against photoaging.
  • Acts by inhibiting tyrosinase activity.
  • Exhibits a considerable lightening in-vivo effect on the skin.
  • Has a completely safe profile.
  • Shows good stability in formulations.
  • Possesses a photoprotective effect on the human epidermal keratinocytes, helping to prevent skin damage caused by UV radiation.
  • Unlike other skin brighteners/lighteners that cause irritation and sensitivity due to the sun, Skinbright Active actually helps to prevent skin damage caused by UV radiation – 190% increase in cell viability.
  • Exhibits a better depigmenting effect than Kojic Acid and Arbutin, and similar to Hydroquinone.
  • Does not affect melanocyte growth, while Hydroquinone cytotoxicity was clearly observed.
  • A cream containing 5% Skinbright Active induces a significant brightening effect after 30 and 60 days.
  • Skinbright active reduced the appearance of melasma (dark skin discolourations that appears on sun-exposed areas of the face) by 72% and lentigines (sun spots, age spots or liver spots) by 67% after 60 days of treatment.
  • Kojic Acid was very efficient but was found that it could cause skin damage so was recently banned in many countries. Skinbright Active has shown better efficiency that Kojic Acid and is very safe to use.
Recommended dosage and how to use in products
Add a minimum of 5% and a maximum of 25% into creams, lotions and, as the product is oil-soluble, to face oils, oil blends and oil serums. We believe it works best in gels.
 
Water or oil-soluble?
Oil-soluble.
 
Can I add it to oil serums or ready-made products?
Yes, mix it in thoroughly.
 
Storage and Shelf life
See label for best before date. Store cool and dark away from direct sunlight.
 
 More information about Skinbright Active
 
Science
The colour of our skin is determined mainly by the amount, distribution and type of melanin, a pigment produced by melanocyte cells in a process called melanogenesis. Melanin synthesis takes place in melanosomes, which contain specific enzymes controlling tegh production of pigments. The first step of melanogenesis is mediated by tyrosinase, a key enzyme that catalyses the first two reactions of melanin synthesis. Abnormal accumulation of melanin is responsible for hyperpigmentations, which could be a serious aesthetic problem.
 
Changes in skin pigmentation
Typical pigmentary changes apppear during intrinsic aging and photoaging:
  • Abnormal accumulation of melanin
  • Acute or persistent UV exposure
Which in turn leads to: Hyperpigmentation: melasma, freckles, age spots and senile lentigines (or more commonly known as age spots, or liver spots, which are benign, localised brownish patch on the skin, often occuring in old age and usually in fair-skinned people with sun-damaged skin.
 
The culture of a brighter skin
Skin brighteners are used worldwide:
  • In Western countries, skin brighteners are applied for the preventiona dn treatment of irregular hyperpigmentation, resulting in a more even skin tone.
  • In Asia, brighter skin is a symbol of beauty and femininity.
  • The use of skin brightening agents is widely extended by traditional beliefs.
 
In vivo tests - Brightening effect
20 healthy Asian female volunteers aged 18 to 46, from  all skin types were selected for this study. The volunteers applied a cream containing 0.1% Skinbright Active  on one side of the face twice daily for 2 months, and a placebo cream on the other side.
The brightening effect was instrumentally evaluated by emans of a Chromameter CR-300. Mean values from 5 successive measurements were calculated. These 6 measurements were rigorously made at the same location at each time.
Measurements were  taken before application, after 30 days and after 60 days of treatment.
After 30 days of treatment, there was significant increase in skin luminance for the skin that was treated with Skinbright Active Cream. The placebo cream presented no significant effects.
After 60 days of treatment, the brightening effect induced by the cream containing Skinbright Active increased in respect to the results at 30 days and it was significantly superior to the effect observed for the placebo cream. In short, the results of the in vivo test prove that Skinbright Active is able to induce a skin brightening effect after 30 and 60 days of treatment.
At the end of the study, no adverse effects were reported by the volunteers.

Conclusion

Generally, skin lightening agents have toxicity-related problems and are only partly effective. New skin brighteners should be developed with guaranteed safety and efficacy. A novel skin brightening agent has been designed to be and effective and safe active ingredient. Skinbright Active showed no cytotoxic effects on melanocytes, keratinocytes or fibroblasts, neither mutagenicity nor any irritation or sensitisation reaction. Its efficacy was tested in cell-free enzymatic assays as well as in cell-based assays. It proved to inhibit both mushroom and endogenous human tyrosinase in vitro, and exhibited a significant depigmenting effect on human melanocytes. The product also proved to have a significant photo-protective effect on human epidermal keratinocyte cell cultures, and can therefore prevent the skin-damaging effects of ultraviolet radiation. Low concentrations of Skinbright Active have demonstrated a significant skinbrightening effect when tested on a panel of human volunteers. In conclusion, Skinbright Active can be classified as a safe skin brightening agent due to its impeccable safety profile and contrasted in vitro and in vivo efficacy.
back to top
Related Products
Other People Also Bought